A Golden Autumn in Beijing | HOPE Wraps Up 93rd PHARMCHINA on a High Note!
Classification:
Company News
Release time:
2026-11-04
Autumn in Beijing, New Chapters in Pharma
The 93rd National Pharmaceutical Trade Fair (PHARMCHINA) is bringing together pharmaceutical companies and industry professionals from China and abroad. As a major event for the pharmaceutical and healthcare sectors, it provides a platform for showcasing products, exchanging expertise, and building business partnerships.
A Meeting of Minds, A World of Possibilities
Held alongside exhibitions covering medical devices, health and nutrition, the event spans a planned exhibition area of 270,000 square meters, bringing together more than 5,000 exhibitors from China and abroad, over 300,000 professional visitor attendances, plus 170+ forums and conference sessions. Bringing together resources from across the industry, the event creates opportunities to share insights, explore market trends, and foster new partnerships.
HOPE in the Spotlight, Engaging Diverse Partners
Beijing HOPE Pharmaceutical Co., Ltd. is showcasing its diverse product portfolio and collaboration opportunities, highlighting its capabilities in active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs).

HOPE team shines brightly
Exchanging Insights, Exploring New Cooperation Prospects
From high-value APIs to a broad range of finished dosage forms, HOPE continues to advance pharmaceutical R&D and commercialization across key therapeutic areas, including oncology, central nervous system (CNS) disorders, and cardiovascular diseases. Certain products have registration documentation and quality standards aligned with the requirements of relevant US and European markets, supporting potential international collaborations. HOPE also offers flexible cooperation models, including API supply, finished product exports, and technology transfer.

The impressive product showcase of HOPE attracts many industry partners.
At the exhibition, the HOPE team is engaging with industry partners to discuss product needs and explore practical collaboration opportunities, laying the groundwork for further market development in China and abroad.

HOPE team engaged in in-depth discussions with visiting clients and partners at the booth.
As autumn settles beautifully over Beijing, we march forward together toward a shared future. HOPE remains committed to advancing pharmaceutical R&D and industrialization. It will actively broaden cooperation, explore fresh opportunities for industry development with partners, and foster coordinated progress across the pharmaceutical and healthcare industry.
Previous Page
Previous Page



